First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy Participants.
Saved in:
| Title: | First‐in‐Human Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Complement Factor D Inhibitor BCX9930 in Healthy Participants. |
|---|---|
| Authors: | Davidson, Matthew1 mdavidson@biocryst.com, Chen, Xilin2, Mathis, Amanda1, Dobo, Sylvia1, Cornpropst, Melanie1, Zhu, Fugang2, Parker, Cynthia2, Reynolds, David1, Babu, Yarlagadda S.2, Mair, Stuart3, Sheridan, William P.1 |
| Source: | Journal of Clinical Pharmacology. Sep2025, Vol. 65 Issue 9, p1116-1126. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00912700 |
|---|---|
| DOI: | 10.1002/jcph.70032 |
